Aspen’s Stephen Saad on South Africa’s vaccination rollout
Saad shares his insights on the pharmaceutical industry, the distribution of the vaccine and threat of Covid-19 variants.
Saad shares his insights on the pharmaceutical industry, the distribution of the vaccine and threat of Covid-19 variants.
10X founder Steven Nathan shares his pearls of wisdom on interesting developments taking place across local and international markets.
South Africa faces an increased risk of load shedding because maintenance needs to be carried out at deteriorating coal-fired power stations.
Short-seller Viceroy Research is subject to a R50m fine from the FSCA for making ‘false, misleading and deceptive statements’ about Capitec.
The IMF has warned that SA should aim to re-prioritise its budget to offset the cost of relief measures for businesses and individuals affected by deadly riots.
Africa “has struggled to procure vaccines and deliveries from Covax have fallen short of projections after India halted exports,” says Bloomberg.
SA will dispose of two million J&J Covid-19 vaccines following a US ruling that ingredients for the country’s doses may have been contaminated.
Aspen was extremely disappointed to learn over the past weekend that specific batches of the J&J vaccines manufactured were contaminated.
“The news marks a major setback in the country’s vaccine rollout just as a third wave of infections is gathering pace”, says Bloomberg.
SA has contracted private companies to help with importation and distribution of vaccines as it seeks to step up vaccination nationwide.